Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |